IGM Biosciences (NASDAQ:IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies. Our lead product candidate, IGM-2323, is a bispecific IgM antibody targeting CD20 x CD3 that is in a Phase 1 clinical trial in patients with relapsed/refractory B cell Non-Hodgkin’s lymphoma (NHL). Our second product candidate is IGM-8444, an agonistic Death Receptor 5 (DR5) IgM antibody that is in a Phase 1 clinical trial in patients with solid cancers and NHL. Also in our product pipeline is IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells.
IGM offers a fast-paced, collaborative, team-based work environment with opportunities to grow professionally and to collaborate with other bright and motivated individuals on cutting edge research and development. We are passionate about what we do, and we are actively hiring for research, development and manufacturing positions at our headquarters in Mountain View, CA.
If you are interested in joining an exciting antibody creation and development company, please see all of our open positions here.
IGM offers a comprehensive benefits package which includes:
New Hire Stock Options
Generous Medical, Dental, and Vision plans
Supplemental Life Insurance
IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.
Notice to Recruiters: We value our recruiting partnerships, but to protect the interest of all parties, IGM does not accept unsolicited resumes from recruiters. All recruiting is managed through our Human Resources Department. Unsolicited resumes submitted through our website or to IGM employees shall be considered the property of IGM Biosciences.